ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma

Title
ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma
Authors
Keywords
A disintegrin and metalloproteinase 17, Amphiregulin, Extracellular matrix metalloproteinase inducer, Matrix metalloproteinase, Cervical carcinoma, Prognostic biomarker
Journal
TUMOR BIOLOGY
Volume 35, Issue 8, Pages 7575-7586
Publisher
Springer Nature
Online
2014-05-03
DOI
10.1007/s13277-014-1990-1

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now